Windlas Biotech

Windlas Biotech EPS

The Earnings per Share (EPS) of Windlas Biotech (WINDLAS.NS) as of Oct 17, 2026 is 31.32 INR. In the previous year, Earnings per Share (EPS) was 28.66 INR — a change of 9.27% (higher).

EPS

31.32INR

YoY

9.27%

Last updated:

Earnings per Share (EPS) of Windlas Biotech is 2026 31.32 INR. Earnings per Share (EPS) of Windlas Biotech was 2025 28.66 INR. It decreases by 9.27% higher compared to the previous year.

The Windlas Biotech EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EPS
Date
EPS
Jan 1, 2019
30.08 INR
Jan 1, 2020
8.91 INR
Jan 1, 2021
7.26 INR
Jan 1, 2022
17.54 INR
Jan 1, 2023
20.50 INR
Jan 1, 2024
27.57 INR
Jan 1, 2025
28.66 INR
Jan 1, 2026
31.32 INR
The Windlas Biotech EPS history
YEAREPSYoY
31.32INR+9.27%
28.66INR+3.97%
27.57INR+34.50%
20.50INR+16.89%
17.54INR+141.70%
7.26INR-18.58%
8.91INR-70.38%
30.08INR+469.94%
5.28INR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Windlas Biotech Stock analysis

What does Windlas Biotech do? Windlas Biotech Ltd is a contract development and manufacturing organization based in Dehradun, Uttarakhand, India. Listed on the National Stock Exchange with ticker WINDLAS.NS, the company employs 1,049 full-time staff. It provides comprehensive CDMO services, including product discovery, development, licensing, and commercial manufacturing of generic products, with a focus on complex generics. The firm specializes in therapeutic areas such as anti-diabetic, cardiovascular, neuropsychiatry, and respiratory treatments. Its capabilities cover formulation development, technology scale-up, and full-scale commercial manufacturing for both solid and liquid pharmaceutical dosage forms. Beyond contract services, Windlas markets its own nutraceutical, pharmaceutical, and Ayurvedic products to semi-urban and rural communities through a salesforce and distribution network spanning over 14 states. The company conducted its initial public offering on August 16, 2021. Windlas Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Windlas Biotech stock

Earnings per Share (EPS) of Windlas Biotech is 31.32 INR in 2026.

Earnings per Share (EPS) of Windlas Biotech changed from 28.66 INR to 31.32 INR, representing a 9.27% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Earnings per Share (EPS) Windlas Biotech since 2006 – with annual values, charts, and detailed analysis.

Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.

EPS = Net Income / Shares Outstanding

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Windlas Biotech

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Windlas Biotech